Internal Medicine, Rheumatology · Hialeah, FL
NPI
1144458233
Since 2009
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7150 W 20th Ave Ste 314
Hialeah, FL, 33016
Phone (786) 620-2361
Groups this clinician bills Medicare through
Medicare paid, 2024
$255K
42,985 services
Medicare patients, 2024
161
Average age 76
Drug cost, 2024
$11.2M
7,459 prescriptions
Company payments, 2025
$2,623
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ricardo J Garcia Alemany was code J3111 (injection, romosozumab-aqqg, 1 mg), 11,341 times for 14 patients. In total Ricardo J Garcia Alemany billed 42,985 services in 30 codes, and Medicare paid $255K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-22.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 11,341 | 14 | $2.95 | $33K |
| J0897 Injection, denosumab, 1 mg | Office | 5,220 | 59 | $13.86 | $72K |
| 99214 Office E&M - Established | Office | 289 | 138 | $101.51 | $29K |
| 96401 Chemotherapy Administration | Office | 262 | 66 | $55.69 | $15K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 75 | 15 | $3.14 | $236 |
| 96413 Chemotherapy Administration | Office | 64 | 11 | $105.53 | $6,754 |
| 99213 Office E&M - Established | Office | 38 | 30 | $70.57 | $2,682 |
| 99204 Office E&M - New | Office | 31 | 31 | $121.03 | $3,752 |
| 36415 Venipuncture Blood Collection | Office | 29 | 18 | $8.65 | $251 |
| 96365 Intravenous Infusion, Hydration | Office | 16 | 16 | $48.32 | $773 |
By year: 2022 $297K for 40,110 services; 2023 $472K for 58,930 services; 2024 $255K for 42,985 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 29 | 18 | $8.65 | $251 |
Medicare prescription drug claims, 2024
In 2024, the drug Ricardo J Garcia Alemany prescribed most often to Medicare patients was Prednisone, with 1,167 prescriptions and refills. In total Ricardo J Garcia Alemany wrote 7,459 Medicare prescriptions that cost $11.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,167 | 1,233 | 260 | $3,690 |
| Methotrexate Methotrexate Sodium | 1,060 | 1,229 | 199 | $5,812 |
| Folic Acid Generic | 545 | 820 | 134 | $1,096 |
| Hydroxychloroquine Sulfate Generic | 390 | 469 | 87 | $4,741 |
| Prolia Denosumab | 357 | 2,142 | 251 | $619K |
| Orencia Abatacept/Maltose | 318 | 318 | 47 | $1.4M |
| Leflunomide Generic | 299 | 371 | 58 | $7,471 |
| Enbrel Sureclick Etanercept | 284 | 284 | 37 | $2.0M |
| Cimzia (2 Pack) Certolizumab Pegol | 273 | 273 | 50 | $1.7M |
| Diclofenac Sodium Generic | 200 | 225 | 66 | $7,785 |
| Allopurinol Generic | 148 | 242 | 35 | $922 |
| Duloxetine Hcl Generic | 145 | 225 | 41 | $1,967 |
| Pregabalin Generic | 141 | 143 | 34 | $3,446 |
| Rinvoq Upadacitinib | 138 | 138 | 19 | $905K |
| Gabapentin Generic | 135 | 146 | 34 | $842 |
Brand drugs: 2,411 claims; generic drugs: 5,018 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ricardo J Garcia Alemany $2,623 ($2,623 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $680.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $680 |
| UCB, Inc. UCB.BR | 12 | $406 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $339 |
| Amgen Inc. AMGN | 13 | $276 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $167 |
| Janssen Biotech, Inc. JNJ | 12 | $147 |
| GlaxoSmithKline, LLC. GSK | 6 | $126 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $121 |
| Aurinia Pharma U.S., Inc. AUPH | 4 | $110 |
| Radius Health, Inc. | 3 | $73.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.